安杰思(688581) - 杭州安杰思医学科技股份有限公司2024年9月投资者关系记录表

Group 1: Company Overview - Company Name: Anjisi Medical Technology Co., Ltd. [2] - Stock Code: 688581 [1] Group 2: R&D Investments and Innovations - The company emphasizes product R&D innovation and has increased investment in this area [2] - Current product developments include endoscopic therapy, fiber imaging technology, and robotic assistance [2] - New products such as interchangeable hemostatic clips are entering the registration phase, with fifth and sixth generation clips under development [2] - In the ERCP field, the company has launched innovative coated guidewires, improving insertion success rates [2] Group 3: International Market Expansion - Overseas sales revenue increased by 35.28% compared to the same period last year [3] - Growth rates by region: Asia-Pacific 82.86%, North America 68.49%, South America 53.74% [3] - Self-owned brand sales account for nearly 30% of total sales [3] - The company plans to expand product lines, sales channels, and academic promotions to enhance market coverage and pricing power [3] Group 4: Production Capacity and Delays - The "annual production of 10 million medical endoscope devices and instruments" project has completed construction and relocated production facilities [3] - The delay in production is due to adjustments in the office area and exhibition hall renovations, which will not impact overall production [3]